WeVote
Log In

Bill

Bill

SB 477

AN ACT RELATING TO INSURANCE -- PRESCRIPTION DRUG BENEFITS

2025 Regular Session Introduced by Bob Britto and 9 co-sponsors

Senate-passed Rhode Island bill modifies prescription drug insurance coverage rules; House committee now reviews impact on drug access and healthcare costs for state residents.

05/07/2025 Referred to House Health & Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 477

Legislative bill overview

SB 477 modifies Rhode Island's insurance regulations governing prescription drug benefits and coverage requirements. The bill has passed the Senate and is now under review by the House Health & Human Services Committee. Specific provisions are not detailed in the available legislative history provided.

Why is this important

Prescription drug policy directly affects healthcare affordability and access for Rhode Island residents, particularly those with chronic conditions requiring ongoing medication. Changes to insurance coverage rules can influence out-of-pocket costs, formulary restrictions, and which medications are available to insured patients.

Potential points of contention

  • Cost burden distribution - Unclear whether changes shift costs toward insurers, employers, or individual consumers through premiums or copayments
  • Drug formulary restrictions - Potential disagreement over whether the bill adequately protects access to non-preferred medications or allows insurers sufficient cost-control mechanisms
  • Insurance market impact - Concerns about whether new requirements could increase insurance premiums or affect insurer participation in Rhode Island's market

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.